Telangana Hyderabad - Bristol Myers Squibb launches Rs 828-cr innovation hub
On Monday, february 26, Bristol Myers Squibb, a major player in the biopharmaceutical industry, opened its newest location in Hyderabad, increasing its worldwide footprint. The new building, which can accommodate more than 1,500 workers, cost more than $100 million to construct (about Rs 828 crore). With the help of its new base, Bristol Myers Squibb wants to advance its mission of developing cutting-edge medical breakthroughs by employing local talent.
D sridhar, the telangana minister for industries and information technology, Dr. christopher Boerner, the chief executive officer of Bristol Myers Squibb, and other authorities were present during the launch. "I am delighted to celebrate the opening of Bristol Myers Squibb's site in Hyderabad," Mr. D sridhar stated in his speech at the ceremony. This is a significant turning point and investment in our dynamic town, providing chances for our talented pool to work at the cutting edge of innovation and research.
"We are grateful for the ongoing collaboration with the government of telangana and are committed to working with them and supporting the local community as we continue to grow our company presence in india," Bristol Myers Squibb Chief Executive Officer christopher Boerner stated.
India is a part of Bristol Myers Squibb's worldwide expansion, and their newest investment is in Hyderabad. The firm has played a significant role in promoting research and delivering patients with important medications for serious illnesses, from Bangalore to Mumbai.
Thanks to its unrelenting commitment to changing lives and reshaping healthcare, Bristol Myers Squibb, with a firm emphasis on cancer, haematology, immunology, and cardiovascular disease, continues to be at the forefront of scientific innovation.
India is a part of Bristol Myers Squibb's worldwide expansion, and their newest investment is in Hyderabad. The firm has played a significant role in promoting research and delivering patients with important medications for serious illnesses, from Bangalore to Mumbai.
Thanks to its unrelenting commitment to changing lives and reshaping healthcare, Bristol Myers Squibb, with a firm emphasis on cancer, haematology, immunology, and cardiovascular disease, continues to be at the forefront of scientific innovation.